$CING

Cingulate Inc. (CING) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. false 0001862150 0001862150 2026-07-17 2026-07-17 0001862150 CING:CommonStockParValue0.0001PerShareMember 2026-07-17 2026-07-17 0001862150 CING:WarrantsExercisableForCommonStockMember 2026-07-17 2026-07-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES

Cingulate Inc. (CING) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. false 0001862150 0001862150 2026-07-09 2026-07-09 0001862150 CING:CommonStockParValue0.0001PerShareMember 2026-07-09 2026-07-09 0001862150 CING:WarrantsExercisableForCommonStockMember 2026-07-09 2026-07-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES

Cingulate Inc. (CING) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. false 0001862150 0001862150 2026-06-30 2026-06-30 0001862150 CING:CommonStockParValue0.0001PerShareMember 2026-06-30 2026-06-30 0001862150 CING:WarrantsExercisableForCommonStockMember 2026-06-30 2026-06-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES

Hargroves Thomas Jeffrey purchased 97,276 indirectly-held shares of Cingulate Inc. (CING) at $5.04 ($0.49M total) on 2026-02-13.

Healthcare stocks rose Tuesday on multiple biotech updates. Bluejay Diagnostics (BJDX) surged 100% after a strategic partnership with Argonaut to advance its Symphony diagnostic platform and announced a private placement up to $23.6M. Picard Medical (PMI) gained 60.33% after completing animal implant studies of its Emperor total artificial heart. Legend Biotech (LEGN) rose 42.22% ahead of EHA Phase 1 data. CUE climbed 18.93% with board changes. Cingulate (CING) rose 11.94% despite the FDA declin

Healthcare biotech gainers on Tuesday included Bluejay Diagnostics (BJDX), which said it signed a strategic partnership with Argonaut to support its Symphony near-patient diagnostic platform; BJDX shares rose 100% to $4.34 and the company also announced a private placement up to $23.6M. Picard Medical (PMI) reported completed animal implant studies for its next-gen Emperor total artificial heart; shares rose 60.33% to $0.27. Legend Biotech (LEGN) said it will present Phase 1 data for LB2501 show

Cingulate Inc. (NASDAQ: CING) has filed an S-3 shelf registration statement to register 4.21 million shares of common stock for resale by selling stockholders. These shares include those issued in a January 2026 private placement, shares from preferred stock conversion, and shares issuable upon warrant exercise. The company will not receive proceeds from resales, but could receive approximately $9.4 million if warrants are fully exercised for cash, which would be used for regulatory approval, development, manufacturing, and commercialization of CTx-1301.

Presentation by ADHD expert Dr. Ann Childress to highlight Phase 3 findings supporting the potential for true, entire active-day symptom control Presentation by ADHD expert Dr. Ann Childress to highlight Phase 3 findings supporting the potential for true, entire active-day symptom control ...

KANSAS CITY, Kan., Oct. 23, 2025 ( GLOBE NEWSWIRE ) -- Cingulate Inc. ( NASDAQ:CING ) , a biopharmaceutical company developing and advancing a pipeline of next-generation pharmaceutical products utilizing its proprietary Precision Timed Release™ ( PTR™ ) drug-delivery platform, today announced ...

Strategic Commercial Supply Agreement Positions Lead Asset CTx-1301 for Launch Pending FDA Approval Strategic Commercial Supply Agreement Positions Lead Asset CTx-1301 for Launch Pending FDA Approval ...